Assess Long-Term Safety of Danicopan Add-on Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria: Analysis of IPIG-Registry Data
Clinical trial NCT07413250 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07413250
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-14
- Primary completion
- 2030-01-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.